Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability
<p>Abstract</p> <p>Background</p> <p>Elucidating the molecular mechanisms by which tumors become resistant to Herceptin is critical for the treatment of Her2-overexpressed metastatic breast cancer.</p> <p>Methods</p> <p>To further understand Herc...
Main Authors: | Kong Sun-Young, Lee Ho-Young, Kim Seok-Ki, Kwon Bumi, Kim Kyung-Hee, Kang Keon, Kang Se, Lee Eun, Jang Sang-Geun, Yoo Byong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/8/286 |
Similar Items
-
Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts
by: Gen Kuroyanagi, et al.
Published: (2022-05-01) -
Herceptin resistance in HER2-moderately expressed breast cancer
by: Kerry, J, et al.
Published: (2012) -
Radiolabeling of Herceptin with 99mTc as a Her2 tracer
by: Samira Heydari, et al.
Published: (2014-08-01) -
Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
by: Soo-Yeon Hwang, et al.
Published: (2020-06-01) -
Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.
by: Praveenkumar K Shetty, et al.
Published: (2012-01-01)